EarlyCell, Inc. — Form D
EarlyCell, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-08. The offering totals $800K, of which $800K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-07-08
- Form: D
- Accession: 0001647361-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $800K
- Minimum investment: $195K
- Investors: 3
- Date of first sale: 2015-06-25
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-243237
Issuer
- Name: EarlyCell, Inc.
- CIK: 0001647361
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 3615 SUPERIOR AVE., SUITE 4407B, CLEVELAND, OH, 44114
- Phone: 216-432-9050
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| ARNON CHAIT | Director | CLEVELAND, OH |
| Ken Reed | Director | Dover, MA |
| Boris Zaslavsky | Director | Cleveland, OH |
| ARNON CHAIT | Executive Officer | CLEVELAND, OH |
| P. David Jackson | Executive Officer | Forest City, CA |
More